Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,237) with videos related to
Page
of 124
Sort By:
Annals of Surgery
|
June 10, 2010
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis
Mechteld C De Jong, Michael B Farnell, Guido Sclabas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis
Kim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
Martin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 29, 2020
Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines
Christopher J Anker, Jadranka Dragovic, Joseph M Herman, et al.
Leukemia
|
July 20, 2016
Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia
L M Saleh, W Wang, S E M Herman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2014
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer
Julius Chapiro, Surojit Sur, Lynn Jeanette Savic, et al.
Practical Radiation Oncology
|
April 16, 2013
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation
Sonali Rudra, Amol K Narang, Timothy M Pawlik, et al.
Annals of Surgical Oncology
|
February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design
Matthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 14, 2011
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience
Peter J Kneuertz, Steven C Cunningham, John L Cameron, et al.
Blood
|
August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
Betty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
Page
of 124
Search research articles
Search
Showing results (1091-1100 of 1,237) with videos related to
Sort By:
Page
of 124
Annals of Surgery
|
June 10, 2010
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis
Mechteld C De Jong, Michael B Farnell, Guido Sclabas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2014
A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis
Kim A Reiss, Joseph M Herman, Marianna Zahurak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
Martin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 29, 2020
Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines
Christopher J Anker, Jadranka Dragovic, Joseph M Herman, et al.
Leukemia
|
July 20, 2016
Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia
L M Saleh, W Wang, S E M Herman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 19, 2014
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer
Julius Chapiro, Surojit Sur, Lynn Jeanette Savic, et al.
Practical Radiation Oncology
|
April 16, 2013
Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation
Sonali Rudra, Amol K Narang, Timothy M Pawlik, et al.
Annals of Surgical Oncology
|
February 26, 2013
Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design
Matthew H G Katz, Robert Marsh, Joseph M Herman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
September 14, 2011
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience
Peter J Kneuertz, Steven C Cunningham, John L Cameron, et al.
Blood
|
August 14, 2013
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
Betty Y Chang, Michelle Francesco, Martin F M De Rooij, et al.
Page
of 124